Latest News by Industry
- Heart of Genetic Counseling Award recognizing excellence in patient care will be presented by Invitae and NSGC -
SAN FRANCISCO, Nov. 10, 2022 /PRNewswire/ -- Researchers from Invitae (NYSE: NVTA), a leading medical genetics company, are presenting research next week at the National Society of Genetic Counselors (NSGC) 41st Annual Conference in Nashville enabling the progress of the science and practice of genetics in patient care. In addition to its research presentations, the company will present the Heart of Genetic Counseling Award, which recognizes excellence in the field of genetic counseling.
The company's research presentations, which include a pre-conference symposium, opening plenary, sponsored session and poster presentations, add to both the science and practice of the fast-growing field of medical genetics. Among the company's poster presentations is a retrospective case-control study aimed to assess the cancer risk for individuals who have a monoallelic MUTYH pathogenic/likely pathogenic variant. In addition, Invitae will present a study highlighting how RNA sequencing can help classify variants predicted to alter RNA splicing, as well as uncovering splice-altering variants in regions outside of the standard reportable range of targeted DNA panels.
"The NSGC annual meeting is a great opportunity for Invitae to show our continued commitment to genetic counselors and their patients as well as furthering the science behind genetic testing," said Robert Nussbaum, M.D., chief medical officer at Invitae. "Working with genetic counselors, we continue to champion affordability, accessibility and innovation – so that we can find answers for more patients, together."
Heart of Genetic Counseling Award
In addition to the research presentations at the meeting, Invitae and NSGC will present the 2022 Heart of Genetic Counseling Award in a ceremony at the NSGC Annual Conference. The Heart of Genetic Counseling Award was established to honor excellence in genetic counseling patient care as recognized by patients themselves. Nominations include stories from patients that highlight both the clinical and personal impact a genetic counselor had on their lives and the lives of their families. The finalists include:
The Heart of Genetic Counseling Award will be presented on Thursday, November 17.
Full presentation schedule
The full schedule of the Invitae presentations at the conference is as follows:
Wednesday, November 16
Thursday, November 17
Friday, November 18
Virtual, on demand for registered attendees
About Invitae
Invitae Corporation (NYSE: NVTA) is a leading medical genetics company, whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time and lower prices. For more information, visit the company's website at invitae.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the benefits and impact of the company's research and collaborations; the potential and importance of genetic testing and genetic counseling services; and the progress of the science and practice of genetics in patient care. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: the company's history of losses; the company's ability to compete; the company's failure to manage growth effectively; the company's need to scale its infrastructure in advance of demand for its tests and to increase demand for its tests; the company's ability to use rapidly changing genetic data to interpret test results accurately and consistently; security breaches, loss of data and other disruptions; laws and regulations applicable to the company's business; and the other risks set forth in the company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022. These forward-looking statements speak only as of the date hereof, and Invitae Corporation disclaims any obligation to update these forward-looking statements.
Contact:
Amanda McQuery
pr@invitae.com
(628) 213-3283
View original content to download multimedia: https://www.prnewswire.com/news-releases/invitae-showcases-advances-in-medical-genomics-at-the-national-society-of-genetic-counselors-nsgc-41st-annual-conference-301674637.html
SOURCE Invitae Corporation